A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...
GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results